Supply chain issues are more likely to result in drug shortages in the United States than in Canada, data suggest.

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

A multi-pronged intervention reduced prior authorization delays and denials for patients treated in a radiation oncology department.

35% lower risk for diabetes, 20% reduced risk for hypertension seen for sugar restriction in first 3 years after conception ...

(HealthDay News) — Elevated baseline resting heart rate (RHR) is associated with an increased risk for incident atrial fibrillation (AF) in Black adults, according to a study published online in JAMA ...

Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...

Credit: Thinkstock Investigators attending ASN’s Kidney Week 2024 reported progress on a number of IgA nephropathy drug ...

Cancer cases and deaths projected to nearly triple in low-HDI countries by 2050 compared with moderate increase in very high-HDI countries ...

Ketoanalogue supplements can enable patients to continue to meet their protein needs without exacerbating nitrogen load.

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Drugs for diabetic kidney disease treatment have greatly expanded, allowing research and consensus on their optimal use.

Updating US dialysis clinics to support hemodiafiltration technology would be necessary to enable its widespread adoption.